BioMedWire Stocks

Health Insurance Keeps 25% of US Employees Locked in Their Jobs

According to the findings of a recent poll conducted by Gallup and West Health, almost a quarter of employees within the U.S., or about 23 million individuals, remain doing jobs they would have otherwise left. They stay due to their desire to retain their health insurance. 

The data shows that “job lock” has been growing over the years and this latest survey indicates an increase of 8% from the number of people who reported being stuck in their jobs due to health insurance concerns in 2021. This comes as costs of healthcare are increasing to levels that are widely considered a crisis that needs to be fixed to tame rising medical costs. 

The survey found that individuals who are facing financial difficulties as a result of their healthcare costs have a higher likelihood of experiencing job lock than those who aren’t experiencing this financial strain. Respondents that admitted to having medical debt had a 44% rate of reporting that they stayed at their jobs so they could retain their health insurance. 

This is compared to a smaller figure, 21%, of people without medical debt that still felt stuck at their jobs so they could retain their health insurance. 

The survey also found that job lock was higher among workers who have been diagnosed with one or more chronic diseases. 29% of employees with chronic conditions say they remain at their workplaces to avoid losing their health insurance while only 17% of those without chronic medical conditions report job lock. 

For individuals with more than three chronic illnesses, job lock soared to 41%, an indicator of how costly it can be to manage these conditions if one doesn’t have extensive health insurance cover. 

In terms of gender, job lock is higher among women (30%) than among men (20%). More women, 22%, also reported having medical debt compared to just 12% of men. Rates of chronic disease were also higher among women (66%) than among men (57%). 

The findings of this survey have several implications not only for policymakers but also for the entire country. Job lock has grown as healthcare costs have risen, which is a big concern because when employees stay at jobs that don’t meet their personal or professional needs anymore, wellbeing declines, workplace accidents increase and productivity suffers. 

It would be interesting to learn what the job lock rates in vulnerable communities, such as racial minorities served by companies like Astiva Health, are, because the picture could be worse than the national averages suggest. 

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Timing of Brain Metastasis Predicts Survival of Colorectal Cancer Patients

A recent study that was conducted on 5,617 people diagnosed with colorectal cancer found that…

4 days ago

From Molecule to Medicine: Onco-Innovations Aligns ONC010 for Clinical Development

Disseminated on behalf of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) and may include paid…

4 days ago

Administering Immunotherapy Prior to Surgery Improves Brain Cancer Treatment Outcomes

A preclinical study conducted by a joint team from Switzerland has found that treatment outcomes for glioblastoma…

5 days ago

Why Many Companies Are Reconsidering Coverage for GLP-1 Drugs

As GLP-1 use has exploded in the U.S., many companies have started discontinuing coverage of…

7 days ago

Earth Science Tech Inc. (ETST) Taps into New Verticals with Zoolzy Acquisition

Earth Science Tech recently completed the acquisition of Zoolzy LLC, a wholesale distributor of active…

1 week ago

New mRNA Platform May Expedite Delivery of Infectious Disease, Cancer Treatments

mRNA vaccines and therapies have had a profound effect on the way various diseases, including…

2 weeks ago